We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| MyoKardia Inc | NASDAQ:MYOK | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 224.91 | 224.42 | 224.91 | 0 | 00:00:00 |
From Feb 2020 to Feb 2025
By Stephen Nakrosis
Shares of MyoKardia Inc. are trading higher in Monday's market, following news the heart drug maker agreed to be acquired by Bristol Myers Squibb in a $13.1 billion deal.
At 11:32 a.m. EDT, MyoKardia's shares were trading 58.06% higher at $220.65. Volume at the time topped 7.7 million shares, above the 65-day average volume of 383,923.
Year to date, MyoKardia shares are up over 202%.
The two companies announced the agreement before the bell Monday, which will see a subsidiary of Bristol Myers Squibb acquire MyoKardia for $225 per share in an all-cash deal.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
October 05, 2020 11:59 ET (15:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year MyoKardia Chart |
1 Month MyoKardia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
